Esryn Pharma Private Limited
About Esryn Pharma Private Limited
Data last updated:
Esryn Pharma Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 August 2022.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24110CH2022PTC044542.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jai Gopal Sharma and Chanchal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 26/3 Industrial Area Phase 2 Chandigarh, Chandigarh, India – 160002.
As per the financials filed for FY 2024, the company reported a revenue of ₹61.18 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.23 Lakh (net margin 2%) and EBITDA of ₹1.42 Lakh (EBITDA margin 2.3%).
Company details
Contact details
Esryn Pharma Private Limited's registered office is in Chandigarh, Chandigarh.
- Registered AddressPlot No 26/3 Industrial Area Phase 2 Chandigarh, Chandigarh, India – 160002
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Esryn Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Esryn Pharma Private Limited, buy the company report.
Financials of Esryn Pharma Private Limited
FY 2025 filings availableEsryn Pharma Private Limited reported revenue of ₹61.18 Lakh (up 1022% YoY) for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹1.42 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹1.23 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2.3% | |
| Net Profit Margin | 2% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Esryn Pharma Private Limited, buy the company report.
Board of directors of Esryn Pharma Private Limited
Esryn Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jai Gopal Sharma Also directs: Exotic Drugs Private Limited | Director | 01 Aug 2022 | 4 Years 2 Months | Current |
| Chanchal | Director | 01 Aug 2022 | 4 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Esryn Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Esryn Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Esryn Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Esryn Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Chanchal was appointed as Director on 01 Aug 2022.
Frequently asked questions
Esryn Pharma is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 August 2022 (4+ years old) and is registered under CIN U24110CH2022PTC044542.
Esryn Pharma has 2 current directors:
- Jai Gopal Sharma - Director
- Chanchal - Director
The latest financial statements of Esryn Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Esryn Pharma is U24110CH2022PTC044542. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Esryn Pharma was incorporated on 01 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Chandigarh.
Chanchal was appointed as Director on 01 Aug 2022. Jai Gopal Sharma was appointed as Director on 01 Aug 2022.
The registered office of Esryn Pharma is at Plot No 263 Industrial Area Phase 2 Chandigarh, Chandigarh, India – 160002.
Esryn Pharma operates in the pharma industry, in the drug formulation and development segment.
Esryn Pharma can be reached at its registered office: Plot No 263 Industrial Area Phase 2 Chandigarh, Chandigarh, India – 160002.
Esryn Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Chandigarh.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
